AI doomerism has become a recurring theme in health technology discussions. In a recent edition of STAT's AI Prognosis newsletter, Brittany Trang offers a few stories to help readers make sense of the AI doom and slowdown talk. The newsletter does not take a definitive stance; instead, it presents a range of reporting that allows clinicians, researchers, and policymakers to weigh the arguments themselves.
For medicine and biotech, the distinction between existential risk and practical slowdown matters. Fears of catastrophic AI outcomes can drive overly cautious regulation, while slowdown narratives may discourage investment in promising tools. Trang's curation provides a framework for evaluating these claims without succumbing to hype or panic.
The newsletter also includes additional items beyond the doom/slowdown theme, rounding out the picture for subscribers. The takeaway is that AI in health care is a complex landscape, and understanding the current discourse is a necessary step for anyone involved in its adoption.